Maze Therapeutics, Inc.
MAZE
Analytical Summary
Maze Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
2-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ |
|---|---|---|
| Operating Margin (%) (%) | — |
34.4%
Excellent
Excellent
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+129%)
|
| Effective Tax Rate (%) (%) |
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
2.2%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
| Profit Margin (%) (%) | — |
31.2%
Excellent
Excellent
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+160%)
|
| FCF Margin (%) (%) | — |
44.7%
Excellent
Excellent
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
| FCF / Net Income (x) |
0.86x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.43x
Good
Good
Free cash flow relative to reported net income
Optimal:
> 1x
|
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ |
|---|---|---|
| Return on Invested Capital (%) |
-40.3%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-18.1%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
| Return on Capital (%) (%) |
-36.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
23.9%
Excellent
Excellent
Operating profit relative to total assets
Optimal:
> 10%
|
| Return on Common Equity (%) (%) |
-36.9%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-346%)
|
-16.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-212%)
|
Secondary lens
Benchmark Lens
Compare MAZE against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare MAZE against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for MAZE
No bullish signals detected
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How MAZE compares to all companies
Peer Comparison
MAZE vs similar peers
Compare MAZE with peers
Stack MAZE against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 2 years · 9 quarters